A single-center experience of non-bioartificial liver support systems among Chinese patients with liver failure

International Journal of Artificial Organs

Volumn 37, Issue 6, 2014, Pages 442-454

  Xia, Qi ^a   Dai, Xiahong ^a   Huang, Jianrong ^a   Xu, Xiaowei ^a   Yang, Qian ^a   Liu, Xiaoli ^a   Chen, Yuemei ^a   Li, Lanjuan ^a  

^a ZHEJIANG UNIVERSITY   (China)

Author keywords

Artificial liver support; Liver failure; Prognosis; Survival

Indexed keywords

DIAGNOSIS; PATIENT TREATMENT;

ACUTE-ON-CHRONIC LIVER FAILURE; ARTIFICIAL LIVER; ARTIFICIAL LIVER SUPPORT; BIOARTIFICIAL LIVER SUPPORT SYSTEM; CLINICAL SYMPTOMS; LIVER DISEASE; LIVER FAILURE; PROGNOSE; SURVIVAL; SURVIVAL RATE;

ARTIFICIAL ORGANS;

HEPARIN;

ACUTE LIVER FAILURE; ACUTE ON CHRONIC LIVER FAILURE; ADULT; ARTICLE; CHINA; CONTINUOUS HEMODIAFILTRATION; DEATH; DIAFILTRATION; FEMALE; FOLLOW UP; GASTROINTESTINAL HEMORRHAGE; HEMOFILTRATION; HEMOLYSIS; HEPATIC ENCEPHALOPATHY; HEPATITIS; HEPATOPULMONARY SYNDROME; HEPATORENAL SYNDROME; HUMAN; HYPERBILIRUBINEMIA; HYPOTENSION; LIVER FAILURE; LIVER SUPPORT; LIVER TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; MODEL FOR END STAGE LIVER DISEASE SCORE; MORTALITY; NON BIOARTIFICIAL LIVER SUPPORT SYSTEM; PLASMAPHERESIS; RETROSPECTIVE STUDY; SUB ACUTE LIVER FAILURE; SURVIVAL RATE; THERAPY EFFECT; TREATMENT OUTCOME; ARTIFICIAL LIVER; MIDDLE AGED; MULTIMODALITY CANCER THERAPY; PROGNOSIS; SEVERITY OF ILLNESS INDEX;

ADULT; CHINA; COMBINED MODALITY THERAPY; FEMALE; HUMANS; LIVER FAILURE; LIVER, ARTIFICIAL; MALE; MIDDLE AGED; PLASMA EXCHANGE; PROGNOSIS; RETROSPECTIVE STUDIES; SEVERITY OF ILLNESS INDEX; SURVIVAL RATE; TREATMENT OUTCOME;

EID: 84904170231     PISSN: 03913988     EISSN: None     Source Type: Journal    
DOI: 10.5301/ijao.5000341     Document Type: Article

References (33)

1. Liver Failure and Artificial Liver Group, Chinese Society of Infectious Diseases, Chinese Medical Association; Severe Liver Diseases and Artificial Liver Group, Chinese Society of Hepatology, Chinese Medical Association. [Diagnostic and treatment guidelines for liver failure] [Article in Chinese]. Zhonghua Gan Zang Bing Za Zhi. 2006;14(9):643-646
2. Ostapowicz G, Fontana RJ, Schiødt FV, et al; U.S. Acute Liver Failure Study Group. Results of a prospective study of acute liver failure at 17 tertiary care centers in the United States. Ann Intern Med. 2002;137(12):947-954
3. Schiodt FV, Atillasoy E, Shakil AO, et al. Etiology and outcome for 295 patients with acute liver failure in the United States. Liver Transpl Surg. 1999;5(1):29-34
4. Lee WM. Acute liver failure in the United States. Semin Liver Dis. 2003;23(3):217-226
5. Katoonizadeh A, Laleman W, Verslype C, et al. Early features of acute-on-chronic alcoholic liver failure: a prospective cohort study. Gut. 2010;59(11):1561-1569
6. Li LJ, Wang ZH, Ye WJ. Artificial liver. Hangzou: ZheJiang University Press; 2012
7. Ling Q, Xu X, Wei Q, et al. Downgrading MELD improves the outcomes after liver transplantation in patients with acute-on-chronic hepatitis B liver failure. PLoS One. 2012;7(1):e30322
8. Du WB, Li LJ, Huang JR, et al. Effects of artificial liver support system on patients with acute or chronic liver failure. Transplant Proc. 2005;37(10):4359-4364
9. Artificial Liver Group Chinese Association of Infectious and Parasitic Diseases. [Operating guide for artificial liver support system] [Article in Chinese]. Zhonghua Gan Zang Bing Za Zhi. 2002;10(5):329-332
10. van den Besselaar AM. Precision and accuracy of the international normalized ratio in oral anticoagulant control. Haemostasis. 1996;26(Suppl 4):248-265
11. Ferenci P, Lockwood A, Mullen K, Tarter R, Weissenborn K, Blei AT. Hepatic encephalopathy-definition, nomenclature, diagnosis, and quantification: final report of the working party at the 11th World Congresses of Gastroenterology, Vienna, 1998. Hepatology. 2002;35(3):716-721
12. Conn HO, Leevy CM, Vlahcevic ZR, et al. Comparison of lactulose and neomycin in the treatment of chronic portalsystemic encephalopathy. A double blind controlled trial. Gastroenterology. 1977;72(4 Pt 1):573-583
13. Cox DR. Regression models and life-tables. J R Stat Soc Series B Stat Methodol 1972;34:187-220
14. Shakil AO, Kramer D, Mazariegos GV, Fung JJ, Rakela J. Acute liver failure: clinical features, outcome analysis, and applicability of prognostic criteria. Liver Transpl. 2000;6(2): 163-169
15. Mas A, Rodés J. Fulminant hepatic failure. Lancet. 1997;349(9058):1081-1085
16. Chen YS, Wu ZW, He JQ, et al. The curative effect of ALSS on 1-month mortality in AoCLF patients after 72 to 120 hours. Int J Artif Organs. 2007;30(10):906-914
17. Yoshiba M, Inoue K, Sekiyama K, Koh I. Favorable effect of new artificial liver support on survival of patients with fulminant hepatic failure. Artif Organs. 1996;20(11):1169-1172
18. Stutchfield BM, Simpson K, Wigmore SJ. Systematic review and meta-analysis of survival following extracorporeal liver support. Br J Surg. 2011;98(5):623-631
19. Mao W, Ye B, Lin S, Fu Y, Chen Y, Chen Y. Prediction value of model for end-stage liver disease scoring system on prognosis in the acute on chronic liver failure patients with plasma exchange treatment. ASAIO J. 2010;56(5):475-478
20. Yu JW, Sun LJ, Zhao YH, Li SC. Prediction value of model for end-stage liver disease scoring system on prognosis in patients with acute-on-chronic hepatitis B liver failure after plasma exchange and lamivudine treatment. J Gastroenterol Hepatol. 2008;23(8 Pt 1):1242-1249
21. Qian Y, Lanjuan L, Jianrong H, et al. Study of severe hepatitis treated with a hybrid artificial liver support system. Int J Artif Organs. 2003;26(6):507-513
22. Li LJ, Yang Q, Huang JR, Xu XW, Chen YM, Fu SZ. Effect of artificial liver support system on patients with severe viral hepatitis: a study of four hundred cases. World J Gastroenterol. 2004;10(20):2984-2988
23. Kjaergard LL, Liu J, Als-Nielsen B, Gluud C. Artificial and bioartificial support systems for acute and acute-on-chronic liver failure: a systematic review. JAMA. 2003;289(2): 217-222
24. Vaid A, Chweich H, Balk EM, Jaber BL. Molecular adsorbent recirculating system as artificial support therapy for liver failure: a meta-analysis. ASAIO J. 2012;58(1):51-59
25. Kribben A, Gerken G, Haag S, et al; HELIOS Study Group. Effects of fractionated plasma separation and adsorption on survival in patients with acute-on-chronic liver failure. Gastroenterology. 2012;142(4):782-789,e3
26. Bernal W, Auzinger G, Dhawan A, Wendon J. Acute liver failure. Lancet. 2010;376(9736):190-201
27. Reuben A, Koch DG, Lee WM; Acute Liver Failure Study Group. Drug-induced acute liver failure: results of a U.S. multicenter, prospective study. Hepatology. 2010;52(6):2065-2076
28. Larson AM, Polson J, Fontana RJ, et al. Acetaminopheninduced acute liver failure: Results of a United States multicenter, prospective study. Hepatology. 2005;42:1364-1372
29. Lee WM. Acetaminophen and the U.S. Acute Liver Failure Study Group: lowering the risks of hepatic failure. Hepatology. 2004;40(1):6-9
30. Lee WM, Squires RH Jr, Nyberg SL, Doo E, Hoofnagle JH. Acute liver failure: Summary of a workshop. Hepatology. 2008;47(4):1401-1415
31. Yang SG, Wang B, Chen P, et al. Effectiveness of HBV vaccination in infants and prediction of HBV prevalence trend under new vaccination plan: findings of a large-scale investigation. PLoS One. 2012;7(10):e47808
32. Polson J, Lee WM; American Association for the Study of Liver Disease. AASLD position paper: the management of acute liver failure. Hepatology. 2005;41(5):1179-1197
33. Sarin SK, Kumar A, Almeida JA, et al. Acute-on-chronic liver failure: consensus recommendations of the Asian Pacific Association for the study of the liver (APASL). Hepatol Int. 2009;3(1):269-282.